Skip to main content
Equibles

JANE STREET GROUP, LLC

Position in NBP — NovaBridge Biosciences

CIK 1595888 NEW YORK, NY
Back to NBP Full portfolio

Position in NBP

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$35,768
+$35,768 QoQ
Shares Held
18,343
Ownership
0.016%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#32
of 49 holders
Holding Since
Dec 2020
12 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in NBP Over Time

Shares Held

Position Value (USD)

Derivatives in NBP

reported options exposure · as of Mar 31, 2026
CallValue
$47,232
CallShares
19,200
PutValue
$0
PutShares
0

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Biotechnology

Healthcare · as of Jun 30, 2026

JANE STREET GROUP, LLC holds $1,372,861,470 across 292 Biotechnology names. NBP ranks #258 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 BBIO
BridgeBio Pharma, Inc.
 2,934,193 $218,538,693
2 MDGL
Madrigal Pharmaceuticals, Inc.
 191,541 $102,847,939
3 AXSM
Axsome Therapeutics, Inc.
 403,995 $98,885,855
4 TGTX
Tg Therapeutics, Inc.
 1,752,646 $96,290,370
5 EXEL
Exelixis, Inc.
 1,402,438 $76,306,651
6 QURE
uniQure N.V.
 1,610,483 $74,178,846
7 HALO
Halozyme Therapeutics, Inc.
 694,684 $54,372,915
8 TVTX
Travere Therapeutics, Inc.
 938,699 $53,327,489

All Filings in NBP

Export CSV
15 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $35,768 18,343
2026-03-31 $47,232 19,200
2025-12-31 $129,671 32,581
2025-12-31 $46,566 11,700
2025-09-30 $38,831 10,273
2023-09-30 $167,958 127,241
2023-03-31 $87,603 25,319
2022-12-31 $307,948 73,672
2022-03-31 $236,633 14,571
2021-12-31 $720,328 15,200
2021-09-30 $1,000,362 13,800
2021-09-30 $11,079,589 152,843
2021-06-30 $1,499,849 17,866
2021-06-30 $654,810 7,800
2020-12-31 $407,093 8,634